Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy
Revista Española de Cardiología (English Edition) · 2023
DOI: 10.1016/j.rec.2023.06.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Revista Española de Cardiología (English Edition), 2023. Verfasst von José M Castellano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centro Integral de Enfermedades Cardiovasculares (CIEC), Hospital Universitario HM Montepríncipe, Grupo HM Hospitales, Madrid, Spain; Facultad HM Hos…. Hauptthemen laut MEDLINE: Cardiovascular Agents, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro Integral de Enfermedades Cardiovasculares (CIEC), Hospital Universitario HM Montepríncipe, Grupo HM Hospitales, Madrid, Spain; Facultad HM Hospitales de Ciencias de la Salud de la Universidad Camilo José Cela, Ma…
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Instituto de Salud Carlos III, Madrid, Spain; Mount Sinai Heart, The Mount Sinai Hospital, Nueva York, United States. Electronic address: valentin.fuster@mount…
Zitieren
APA
Castellano, J. M., & Fuster, V. (2023). Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2023.06.019
Vancouver
Castellano JM, Fuster V. Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy. Revista Española de Cardiología (English Edition). 2023. doi:10.1016/j.rec.2023.06.019
BibTeX
@article{Castellano2023,
author = {Castellano, José M and Fuster, Valentín},
title = {Scientific development of the CNIC cardiovascular polypill: from conceptualization to clinical efficacy},
journal = {Revista Española de Cardiología (English Edition)},
year = {2023},
doi = {10.1016/j.rec.2023.06.019}
}
EUVIMED